ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1137

REMS Technology for the Assessment of Bone Health in a Male Population

Delia Ciardo1, Paola Pisani1, Fiorella Anna Lombardi1, Marco Di Paola1, Roberto Franchini1, Maurizio Muratore2, Francesco Conversano1 and Sergio Casciaro1, 1National Research Council, Institute of Clinical Physiology, Lecce, Italy, Lecce, Italy, 2Vito Fazzi Hospital, ASL-LE, O.U. of Rheumatology, Lecce, Italy, Lecce, Italy

Meeting: ACR Convergence 2021

Keywords: osteoporosis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster (1135–1149)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: This study aimed to evaluate the diagnostic accuracy of the ultrasound-based densitometric technology called Radiofrequency Echographic Multi Spectrometry (REMS) in the diagnosis of osteoporosis in a population of adult male patients based on lumbar spine scans, compared to Dual-energy X-ray Absorptiometry (DXA), considered as a reference.

Methods: Inclusion criteria were: Caucasian male patients, aged between 30 and 90 years, body mass index (BMI) less than 40 kg/m2, no significant walking impairments, referral for lumbar spine DXA. Signed informed consent was obtained. The patients underwent a lumbar spine scans with both DXA and REMS.

The correlation between REMS and DXA-measured BMD was expressed by Pearson correlation coefficient. Bland-Altman plot was also obtained. Patients were classified as “with osteoporosis” or “without osteoporosis” on the base of the T-score value using the conventional threshold (-2.5) for both techniques independently. Considering the DXA outcome as reference, the accuracy of the diagnostic classification was assessed as sensitivity, specificity, Cohen’s K and 3-classes diagnostic concordance.

Results: Three hundred and thirteen patients were considered, with mean age of 57.7 years (range: 30 to 87 years). The Pearson correlation coefficient between REMS- and DXA-measured BMD values was r=0.92 (r2=0.85). At Bland-Altman analysis, bias ± 2 standard deviations were -0.002 ± 0.092 g/cm2.

The agreement in diagnostic classification performed by REMS and by DXA was very high, with a sensitivity of 89.1% and specificity of 90.7%. Cohen’s K was 0.71. Considering the 3 diagnostic classes (normal bone, osteopenia, osteoporosis), the diagnostic concordance between technologies was 81.5%.

Conclusion: REMS, applied to the lumbar spine site, is a reliable technology for the diagnosis of osteoporosis in men, thus confirming the diagnostic performance already observed in studies carried out in female populations [1, 2].

References

  1. Di Paola P et al. Osteoporos Int. 30(2):391-402.
  2. Adami G et al. Bone 2020 May;134:115297

Disclosures: D. Ciardo, None; P. Pisani, None; F. Lombardi, None; M. Di Paola, None; R. Franchini, None; M. Muratore, None; F. Conversano, None; S. Casciaro, None.

To cite this abstract in AMA style:

Ciardo D, Pisani P, Lombardi F, Di Paola M, Franchini R, Muratore M, Conversano F, Casciaro S. REMS Technology for the Assessment of Bone Health in a Male Population [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/rems-technology-for-the-assessment-of-bone-health-in-a-male-population/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rems-technology-for-the-assessment-of-bone-health-in-a-male-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology